Profile data is unavailable for this security.
About the company
PT Merck Tbk is an Indonesia-based vibrant science and technology company. The Company delivers personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. The Company operates through three segments: Biopharma (ethical products), Consumer Health (over-the-counter products) and Others.
- Revenue in IDR (TTM)934.62bn
- Net income in IDR124.91bn
- Incorporated1970
- Employees376.00
- LocationMerck Tbk PTJl. TB. Simatupang No. 8, Pasar ReboJAKARTA TIMUR 13760IndonesiaIDN
- Phone+62 28565600
- Fax+62 28565601
- Websitehttps://www.merckgroup.com/id-id
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arch Biopartners Inc | 15.77bn | -29.31bn | 1.42tn | -- | -- | -- | -- | 90.18 | -0.0409 | -0.0409 | 0.0221 | -0.1021 | 0.9363 | -- | 1.88 | -- | -174.05 | -214.82 | -- | -- | -- | -- | -185.89 | -180.45 | -- | -3.57 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
| Turk Ilac Ve Serum Sanayi AS | 1.19tn | 42.65bn | 1.42tn | 465.00 | 33.40 | 1.77 | 21.20 | 1.20 | 0.5704 | 0.5704 | 15.85 | 10.77 | 0.998 | 7.39 | 2.42 | 5,842,276.00 | 3.59 | 3.05 | 5.11 | 5.26 | 31.30 | 23.44 | 3.60 | 2.36 | 1.97 | 1.16 | 0.4749 | 0.00 | 16.88 | 81.44 | 229.47 | 49.00 | 37.65 | -- |
| Nectar Lifesciences Ltd | 3.17tn | 20.22bn | 1.45tn | 1.69k | 71.93 | 0.7133 | 10.71 | 0.4578 | 0.4766 | 0.4766 | 73.70 | 48.06 | 0.7764 | 1.67 | 4.94 | 9,960,952.00 | 0.496 | -0.2956 | 0.8778 | -0.541 | 30.41 | 16.49 | 0.6388 | -0.4053 | 0.5576 | 1.25 | 0.3686 | -- | 10.53 | -9.56 | 120.66 | -36.29 | -5.06 | -- |
| Chunghwa Chemical Synthsis&Biotech CoLtd | 741.80bn | 47.75bn | 1.45tn | 243.00 | 30.54 | 0.891 | 10.20 | 1.96 | 1.26 | 1.26 | 19.52 | 43.04 | 0.3063 | 0.9709 | 5.92 | -- | 1.97 | 9.03 | 2.27 | 10.56 | 31.22 | 43.26 | 6.44 | 20.15 | 0.9154 | -- | 0.2319 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| Ste Promotion Pharmaceutique du Mghrb SA | 1.36tn | 88.57bn | 1.46tn | -- | 16.51 | 1.81 | 9.47 | 1.07 | 55.72 | 55.72 | 856.35 | 507.85 | 0.8612 | 1.70 | 4.01 | -- | 5.60 | 9.96 | 9.01 | 14.49 | 42.40 | 50.14 | 6.51 | 9.69 | 1.16 | 14.77 | 0.3211 | -- | 14.32 | 12.62 | -24.42 | 7.99 | 53.54 | -- |
| Assertio Holdings Inc | 2.00tn | -1.09tn | 1.47tn | 53.00 | -- | 0.7056 | -- | 0.7321 | -0.7212 | -0.7212 | 1.32 | 1.37 | 0.3834 | 0.9052 | 2.34 | 2,372,887.00 | -20.88 | -21.51 | -30.33 | -32.05 | 70.31 | 88.68 | -54.46 | -62.10 | 1.57 | -- | 0.2293 | -- | -2.67 | -13.38 | -402.80 | -- | -28.25 | -- |
| Bangkok Lab and Cosmetic PCL | 701.37bn | 76.53bn | 1.47tn | 698.00 | 19.24 | 1.99 | 14.12 | 2.10 | 0.278 | 0.278 | 2.55 | 2.69 | 0.6961 | 2.56 | 4.73 | 2,190,737.00 | 7.81 | 6.01 | 9.71 | 13.28 | 30.74 | 27.33 | 11.22 | 5.68 | 3.08 | 16.42 | 0.1158 | -- | 8.50 | 17.54 | 15.65 | 51.84 | 19.54 | -- |
| Lee's Pharmaceutical Holdings Ltd | 2.45tn | 129.03bn | 1.48tn | 993.00 | 11.49 | 0.4227 | 3.69 | 0.604 | 0.1071 | 0.1071 | 2.04 | 2.91 | 0.4403 | 2.11 | 9.70 | 1,134,410.00 | 1.98 | 13.33 | 2.52 | 17.76 | 51.49 | 61.92 | 4.50 | 36.20 | 0.7425 | 6.58 | 0.132 | 3.59 | -14.61 | -1.53 | -67.44 | -47.49 | -12.19 | -31.34 |
| Biosyent Inc | 385.47bn | 81.49bn | 1.51tn | 0.00 | 18.70 | 3.66 | 17.34 | 3.91 | 0.5988 | 0.5988 | 2.83 | 3.06 | 0.8352 | 1.34 | 7.74 | -- | 17.66 | 14.77 | 20.16 | 16.92 | 79.77 | 79.74 | 21.14 | 19.99 | 4.90 | -- | 0.0309 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Merck Tbk PT | 934.62bn | 124.91bn | 1.53tn | 376.00 | 12.23 | 2.09 | 9.19 | 1.63 | 278.81 | 278.81 | 2,086.21 | 1,628.52 | 1.01 | 1.61 | 6.34 | 2,396,464,000.00 | 13.54 | 12.78 | 16.05 | 18.12 | 34.90 | 40.53 | 13.36 | 14.06 | 1.70 | -- | 0.0247 | 79.25 | -14.51 | 9.46 | -0.8884 | 36.67 | -3.13 | -34.05 |
Data as of Nov 22 2024. Currency figures normalised to Merck Tbk PT's reporting currency: Indonesian Rupiah IDR
0.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Samarang LLPas of 30 Jun 2022 | 2.92m | 0.65% |
Data from 30 Jun 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
